Cargando…
The multi-target aspect of an MmpL3 inhibitor: The BM212 series of compounds bind EthR2, a transcriptional regulator of ethionamide activation
The emergence of drug-resistant strains of Mycobacterium tuberculosis (Mtb) ensures that drug discovery efforts remain at the forefront of TB research. There are multiple different experimental approaches that can be employed in the discovery of anti-TB agents. Notably, inhibitors of MmpL3 are numer...
Autores principales: | Moorey, Alice R., Cabanillas, Alejandro, Batt, Sarah M., Ghidelli-Disse, Sonja, Urones, Beatriz, Sanz, Olalla, Lelievre, Joel, Bantscheff, Marcus, Cox, Liam R., Besra, Gurdyal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634040/ https://www.ncbi.nlm.nih.gov/pubmed/34888432 http://dx.doi.org/10.1016/j.tcsw.2021.100068 |
Ejemplares similares
-
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters
por: Nikiforov, Petar O., et al.
Publicado: (2016) -
Fragment-Sized EthR Inhibitors Exhibit Exceptionally
Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium
tuberculosis Assays
por: Nikiforov, Petar O., et al.
Publicado: (2017) -
Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection
por: Poce, Giovanna, et al.
Publicado: (2013) -
Two-Way Regulation of MmpL3 Expression Identifies
and Validates Inhibitors of MmpL3 Function in Mycobacterium
tuberculosis
por: Grover, Shipra, et al.
Publicado: (2020) -
MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
por: Varela, Cristian, et al.
Publicado: (2012)